MS

Mahendra Singh

Active Director Director DIN 09612746
DIN 09612746 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Mahendra Singh

Data last updated:

Mahendra Singh is a Director at Atyanat Pharmaceuticals India Private Limited (since 2022). The company operates in Pharma. Atyanat Pharmaceuticals India Private Limited reported revenue of ₹1.18 Cr (FY 2023).

DIN 09612746
Primary Designation Director
Industry Pharma
First Appointment 20 May 2022
Oldest Company Age 4 yrs
Largest company Atyanat Pharmaceuticals India Private Limited · ₹1.18 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 May 20222022₹1.18 Cr (FY 2023)Active

Board colleagues of Mahendra Singh

NameDINCompanyDesignation
Chitraprabha09612745Atyanat Pharmaceuticals India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Atyanat Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Mahendra Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendra Singh

Mahendra Singh currently holds 1 directorship: Atyanat Pharmaceuticals India Private Limited (Director, since 20 May 2022, revenue ₹1.18 Cr (FY 2023)).

Mahendra Singh was first appointed on 20 May 2022 as Director at Atyanat Pharmaceuticals India Private Limited.

The current boards of Mahendra Singh's companies include Chitraprabha (Atyanat Pharmaceuticals India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available